Paul B Manning Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Paul B Manning is of Candel Therapeutics, Inc.. Currently has a direct ownership of 56,000 shares of CADL, which is worth approximately $490,000. The most recent transaction as insider was on Jul 29, 2021, when has been sold 20,000 shares (Common Stock) at a price of $7.3 per share, resulting in proceeds of $146,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56K
0% 3M change
0% 12M change
Total Value Held $490,000

Paul B Manning Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 29 2021
BUY
Open market or private purchase
$146,000 $7.3 p/Share
20,000 Added 26.32%
56,000 Common Stock
Jul 27 2021
BUY
Open market or private purchase
$264,960 $7.36 p/Share
36,000 Added 50.0%
36,000 Common Stock

Also insider at

TSHA
Taysha Gene Therapies, Inc. Healthcare
LQDA
Liquidia Corp Healthcare
Director
VRCA
Verrica Pharmaceuticals Inc. Healthcare
ABOS
Acumen Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
PBM

Paul B Manning

Charlottesville, VA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL